We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+15.53%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$38.7B
AUM Growth
+$5.1B
(+15%)
Cap. Flow
+$551M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
24.47%
Holding
1,486
New
101
Increased
869
Reduced
411
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$130M |
| 2 |
Franco-Nevada
FNV
|
+$128M |
| 3 |
B
Barrick Mining
B
|
+$98.9M |
| 4 |
Dominion Energy
D
|
+$96M |
| 5 |
Monolithic Power Systems
MPWR
|
+$88.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$133M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$104M |
| 3 |
SLB Ltd
SLB
|
+$90.4M |
| 4 |
Blackrock
BLK
|
+$89.1M |
| 5 |
Honeywell
HON
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 35.79% |
| 2 | Technology | 25.85% |
| 3 | Energy | 9% |
| 4 | Healthcare | 6.56% |
| 5 | Financials | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Unity
U
$14.6B
| $28.4M | 0.07% |
994,960
+39,633
| +4% | +$1.24M |
|
|
PLL
202
DELISTED
Piedmont Lithium
PLL
| $28.4M | 0.07% |
644,189
-74,860
| -10% | -$4.15M |
|
203
Cencora
COR
$60.7B
| $28.3M | 0.07% |
170,778
-15,049
| -8% | -$2.38M |
|
204
Takeda Pharmaceutical
TAK
$55.1B
| $27.8M | 0.07% |
1,785,206
-76,816
| -4% | -$1.07M |
|
205
Nike
NKE
$62.7B
| $26.7M | 0.07% |
227,986
-5,935
| -3% | -$598K |
|
206
AGCO
AGCO
$7.76B
| $26.6M | 0.07% |
191,837
-15,135
| -7% | -$1.87M |
|
207
Sanofi
SNY
$103B
| $26.5M | 0.07% |
547,031
-65,364
| -11% | -$2.87M |
|
208
GSK
GSK
$104B
| $26.1M | 0.07% |
743,913
-74,421
| -9% | -$2.48M |
|
209
Accenture
ACN
$99.9B
| $26M | 0.07% |
97,570
+1,824
| +2% | +$505K |
|
|
MRO
210
DELISTED
Marathon Oil Corporation
MRO
| $25.8M | 0.07% |
951,425
-5,804
| -0.6% | -$168K |
|
211
Viatris
VTRS
$20.7B
| $25.6M | 0.07% |
2,297,905
+300,343
| +15% | +$3.14M |
|
212
IQVIA
IQV
$39.1B
| $25.1M | 0.06% |
122,566
+21,570
| +21% | +$4.37M |
|
213
Southern Company
SO
$106B
| $24.9M | 0.06% |
349,033
+90,198
| +35% | +$6.03M |
|
|
SVM
214
Silvercorp Metals
SVM
$2.13B
| $24.8M | 0.06% |
8,366,073
+193,401
| +2% | +$524K |
|
215
Abbott
ABT
$183B
| $24.7M | 0.06% |
224,811
-3,697
| -2% | -$383K |
|
216
Main Street Capital
MAIN
$5.06B
| $24.5M | 0.06% |
662,192
+71,092
| +12% | +$2.6M |
|
217
Duke Energy
DUK
$98.4B
| $24.4M | 0.06% |
236,493
+60,277
| +34% | +$5.79M |
|
218
VanEck Merk Gold Trust
OUNZ
$2.55B
| $24.1M | 0.06% |
1,363,224
-66,248
| -5% | -$1.11M |
|
219
Teva Pharmaceuticals
TEVA
$41.2B
| $24.1M | 0.06% |
2,643,100
+348,658
| +15% | +$3.04M |
|
220
Shell
SHEL
$250B
| $23.8M | 0.06% |
418,250
-410
| -0.1% | -$22.6K |
|
221
Golub Capital BDC
GBDC
$3.34B
| $23.8M | 0.06% |
1,804,957
+56,869
| +3% | +$750K |
|
|
BDXB
222
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
| $23.7M | 0.06% |
473,278
+4,809
| +1% | +$232K |
|
223
Prospect Capital
PSEC
$1.08B
| $23.7M | 0.06% |
3,384,568
+191,888
| +6% | +$1.38M |
|
224
Illumina
ILMN
$31B
| $23.5M | 0.06% |
119,558
+16,117
| +16% | +$3.34M |
|
225
Hercules Capital
HTGC
$2.98B
| $23.4M | 0.06% |
1,769,236
+87,293
| +5% | +$1.19M |
|
Similar funds
VanEck Associates's Q4 2022 Portfolio in Review
As of Q4 2022, VanEck Associates held 1,486 positions worth $38.7B, up 15% from $33.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
VanEck Associates's Q4 2022 filing shows 101 new, 869 increased, 411 reduced and 62 closed positions. Its largest new stake was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M. The largest sale was Gilead Sciences, an estimated $133M.
By sector, the portfolio is most concentrated in Materials at 36% of assets, up from 34% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q4 2022 buy was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M.
- VanEck Associates added most to Newmont in Q4 2022, an estimated $130M increase.
- VanEck Associates's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $133M.
- VanEck Associates fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q4 2022, selling an estimated $29.4M.
- VanEck Associates's ten largest holdings make up 24% of its $38.7B portfolio in Q4 2022.
- VanEck Associates opened 101 new positions and closed 62 in Q4 2022.
- VanEck Associates's portfolio value rose 15% quarter-over-quarter to $38.7B.
Based on VanEck Associates's 13F filing for Q4 2022, filed 8 Feb 2023.